Global Structural Heart Disease Treatment Devices Market 2020-2024| Evolving Opportunities

ELMHURST, Ill. - Jan. 9, 2020 - PRLog -- The global structural heart disease treatment devices market since 2018 and the market is poised to grow by USD 5.61 billion during 2020-2024 at a CAGR of over 10% during the forecast period.

The increasing prevalence of structural heart diseases and technological innovations in structural heart disease treatment are anticipated to boost the growth of the market.
The prevalence of structural heart diseases such as aortic stenosis, heart valve disease, valvular stenosis, and congenital heart defects is increasing around the globe. According to the NIH, in 2019, about 10% of the population aged 75 and above were found with degenerative abnormalities associated with severe aortic stenosis and mitral and tricuspid regurgitation. The increased life expectancy in the elderly population is increasing the prevalence of heart valve diseases such as CHD. This will increase the demand for structural heart disease treatment devices and drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing - https://www.technavio.com/report/structural-heart-disease...

Major Five Structural Heart Disease Treatment Devices Market Companies:

Abbott Laboratories
Abbott Laboratories is headquartered in the US and operates the business under various segments such as Established Pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and Neuromodulation. The company offers AMPLATZER PFO Occluder, MitraClip, and Trifecta GT aortic valve.

Becton, Dickinson and Co.
Becton, Dickinson and Co. is headquartered in the US and offers products through the following business units: Medical, Life Sciences, and Interventional. The company offers TRUE Dilatation balloon valvuloplasty catheters and TRUE Flow valvuloplasty perfusion catheter.

Boston Scientific Corp.
Boston Scientific Corp. is headquartered in the US and operates under various business segments, namely MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers WATCHMAN and LOTUS Edge Aortic Valve System.

Braile Biomédica
Braile Biomédica is headquartered in Brazil and offers products through the following business segments: Biological, Cardiovascular, Electromedicals, Endovascular, Oncology, and Transcatheter. The company offers Malleable Valve Annuloplasty Ring and Organic Valve Prosthesis Porcine.


Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.
Request a free sample report - https://www.technavio.com/talk-to-us?report=IRTNTR40733&a...